Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 225 | 0 | 0 | 0 | 0 |
| Gross Profit | 225 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,581 | 2,481 | 2,089 | 2,108 | 2,341 |
| Operating Income | -2,356 | -2,481 | -2,089 | -2,108 | -2,341 |
| Other Income | 57 | 55 | 40 | 53 | 40 |
| Pre-tax Income | -2,299 | -2,426 | -2,049 | -2,055 | -2,301 |
| Net Income Continuous | -2,299 | -2,426 | -2,049 | -2,055 | -2,301 |
| Net Income | $-2,299 | $-2,426 | $-2,049 | $-2,055 | $-2,301 |
| EPS Basic Total Ops | -0.17 | -0.16 | -0.19 | -0.20 | -0.23 |
| EPS Basic Continuous Ops | -0.17 | -0.17 | -0.19 | -0.20 | -0.23 |
| EPS Diluted Total Ops | -0.17 | -0.16 | -0.19 | -0.20 | -0.23 |
| EPS Diluted Continuous Ops | -0.17 | -0.17 | -0.19 | -0.20 | -0.23 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.17 | -0.19 | -0.20 | -0.23 |
| EBITDA(a) | $-2,344 | $-2,390 | $-1,999 | $-1,938 | $-2,316 |